NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces New Data at European Breast Cancer Conference that Further Supports Use of MammaPrint and BluePrint Tests
Presentation Shows MammaPrint Can Accurately Stratify Recurrence Risk up to 25 Years IRVINE, CA and AMSTERDAM, March 26, 2014 โ Four scientific presentations at the 9th European Breast Cancer Conference (EBCC) underscored the international scope Read More
Agendia Co-Founder Awarded EU Prize for Women Innovators
Laura van โt Veer, Ph.D., Honored as Inventor of MammaPrint Breast Cancer Test ย ย ย IRVINE, CA and AMSTERDAM, March, 10, 2014 โ Agendia co-founder Laura van โt Veer, Ph.D., has been awarded a 2014 Read More
Agendia Test for Molecular Subtyping of Breast Cancer Shown to Better Identify Risk of Disease Recurrence
Scientific Poster and Symposium at Miami Breast Cancer Conference Demonstrateย Value of MammaPrint and BluePrint Tests Compared to First-Generation Testย IRVINE, CA and AMSTERDAM, March, 11, 2014 โ A scientific poster comparing Agendiaโs MammaPrintยฎ and BluePrintยฎ Read More